Becker's Cardiology

Advertisement


The Latest

Arlington, Va.-based VHC Health named Brian Choi, MD, chief of heart and vascular services, effective Aug. 31. As chief, Dr. Choi will provide strategic and clinical leadership to the system’s cardiovascular programs, integrate and grow cardiovascular services, enhance patient experience…

Boston-based Mass General Brigham’s Heart and Vascular Institute is changing its approach to care, workforce relationships and research to innovate on the model inside of an academic medical center.  The institute brings together cardiology, cardiac surgery and vascular surgery, all…

The Kansas State Board of Healing Arts has suspended the license of a Texas-based physician indicted in an alleged $89 million cardiovascular testing fraud scheme, KSNT reported Oct. 1. The board issued a 90-day order of immediate suspension Sept. 29…

Transplanted hearts may change to match the biological age of the recipient, a new study suggests.  The study, posted on the preprint server bioRxiv, is not yet peer reviewed. Researchers from Boston-based Harvard University conducted heart transplants in mice and…

Springfield, Mass.-based Baystate Health named Amir Lotfi, MD, chief medical officer, effective Sept. 28. As CMO, Dr. Lotfi will provide systemwide clinical leadership and oversee quality measurement, clinical quality improvement, patient and team member safety, peer review, infection control, and…

U.S. News and World Report rated 519 hospitals as high performing for heart arrhythmia care. U.S. News evaluated roughly 4,500 hospitals on how well they treated heart arrhythmia patients by analyzing patient survival rates, recovery at home, number of patients…

The American College of Surgeons found that more than 80% of U.S. counties do not have a practicing vascular, thoracic or transplant surgeon. The ACS used data from the 2025 National Plan and Provider Enumeration System, CMS Provider of Services…

Inventia Healthcare Limited has recalled 13,567 bottles of chlorthalidone tablets after the product failed dissolution specifications. The voluntary recall covers Chlorthalidone Tablets, USP, 25 milligram, packaged in 100-tablet bottles and distributed nationwide, according to an FDA enforcement report. The affected…

Advertisement

Advertisement